Please use this identifier to cite or link to this item: https://doi.org/10.1111/cas.13424
Title: PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer
Authors: Mimura K.
Teh J.L.
Okayama H.
Shiraishi K.
Kua L.-F.
Koh V.
Smoot D.T.
Ashktorab H.
Oike T.
Suzuki Y.
Fazreen Z.
Asuncion B.R.
Shabbir A. 
Yong W.-P.
So J. 
Soong R. 
Kono K.
Keywords: CD8
gastric cancer
IFN-?
PD-L1
TILs
Issue Date: 1-Jan-2018
Publisher: Blackwell Publishing Ltd
Citation: Mimura K., Teh J.L., Okayama H., Shiraishi K., Kua L.-F., Koh V., Smoot D.T., Ashktorab H., Oike T., Suzuki Y., Fazreen Z., Asuncion B.R., Shabbir A., Yong W.-P., So J., Soong R., Kono K. (2018-01-01). PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer. Cancer Science 109 (1) : 43-53. ScholarBank@NUS Repository. https://doi.org/10.1111/cas.13424
Abstract: Despite multidisciplinary treatment for patients with advanced gastric cancer, their prognosis remains poor. Therefore, the development of novel therapeutic strategies is urgently needed, and immunotherapy utilizing anti-programmed death 1/-programmed death ligand-1 mAb is an attractive approach. However, as there is limited information on how programmed death ligand-1 is upregulated on tumor cells within the tumor microenvironment, we examined the mechanism of programmed death ligand-1 regulation with a particular focus on interferon gamma in an in爒itro setting and in clinical samples. Our in爒itro findings showed that interferon gamma upregulated programmed death ligand-1 expression on solid tumor cells through the JAK-signal transducer and activator of transcription pathway, and impaired the cytotoxicity of tumor antigen-specific CTL against tumor cells. Following treatment of cells with anti-programmed death ligand-1 mAb after interferon gamma-pre-treatment, the reduced anti-tumor CTL activity by interferon gamma reached a higher level than the non-treatment control targets. In contrast, programmed death ligand-1 expression on tumor cells also significantly correlated with epithelial-mesenchymal transition phenotype in a panel of solid tumor cells. In clinical gastric cancer samples, tumor membrane programmed death ligand-1 expression significantly positively correlated with the presence of CD8-positive T cells in the stroma and interferon gamma expression in the tumor. The results suggest that gastric cancer patients with high CD8-positive T-cell infiltration may be more responsive to anti-programmed death 1/-programmed death ligand-1 mAb therapy. � 2017 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
Source Title: Cancer Science
URI: http://scholarbank.nus.edu.sg/handle/10635/146666
ISSN: 13479032
DOI: 10.1111/cas.13424
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
cas.13424.pdf1.51 MBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

5
checked on Sep 17, 2018

Page view(s)

4
checked on Sep 6, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.